✦ LIBER ✦

Low-dose Fractionated Radiation (LDFRT) as a Chemopotentiator of Neoadjuvant Paclitaxel and Carboplatin for Locally Advanced Squamous Cell Carcinoma of the Head and Neck: 5 Year Results Of A Prospective Phase II Trial

✍ Scribed by Gleason, J.F.; Kudrimoti, M.; Van Meter, E.M.; Mohiuddin, M.; Regine, W.F.; Valentino, J.; Arnold, S.M.

Book ID: 122562859
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 51 KB
Volume: 81
Category: Article
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2011.06.1026

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Radiation therapy alone or with concurre

Radiation therapy alone or with concurrent low-dose daily either cisplatin or carboplatin in locally advanced unresectable squamous cell carcinoma of the head and neck: a prospective randomized trial

✍ Branislav Jeremic; Yuta Shibamoto; Bozidar Stanisavljevic; Ljubisa Milojevic; Bi 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 986 KB

Paclitaxel, cisplatin, 5-fluorouracil an

Paclitaxel, cisplatin, 5-fluorouracil and radiotherapy in the management of advanced squamous cell carcinoma of the head and neck. A phase II trial

✍ Marco Merlano; Elvio G. Russi; Gianmauro Numico; Ida Colantonio; Ornella Garrone 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Hyperfractionated radiation therapy with

Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial

✍ B Jeremic; Y Shibamoto; B Milicic; N Nikolic; A Dagovic; J Aleksandrovic; Z Vask 📂 Article 📅 2001 🏛 Elsevier Science 🌐 French ⚖ 12 KB

Neoadjuvant continuous infusion of weekl

Neoadjuvant continuous infusion of weekly 5-fluorouracil and escalating doses of oxaliplatin plus concurrent radiation in locally advanced oesophageal squamous cell carcinoma: results of a phase I/II trial

✍ Lorenzen, S; Brücher, B; Zimmermann, F; Geinitz, H; Riera, J; Schuster, T; Roeth 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 156 KB

A phase 2 trial of induction nab-paclita

A phase 2 trial of induction nab-paclitaxel and cetuximab given with cisplatin and 5-fluorouracil followed by concurrent cisplatin and radiation for locally advanced squamous cell carcinoma of the head and neck

✍ Douglas Adkins; Jessica Ley; Kathryn Trinkaus; Wade Thorstad; James Lewis Jr; Ta 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 274 KB

Phase I and initial phase II results fro

Phase I and initial phase II results from a trial investigating weekly docetaxel and carboplatin given neoadjuvantly and then concurrently with concomitant boost radiotherapy for locally advanced squamous cell carcinoma of the head and neck

✍ David L. Schwartz; R. Bruce Montgomery; Bevan Yueh; Michael Donahue; Yoshimi Anz 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB 👁 2 views

## Abstract ## BACKGROUND The current Phase I/II study assessed induction docetaxel/carboplatin given weekly for 4 weeks, followed by weekly docetaxel/carboplatin and concomitant boost radiotherapy (CB‐XRT) for locally advanced head and neck squamous cell carcinoma. ## METHODS Twenty patients wi